TrialCancer science2020

Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.

Hitoshi Kiyoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.